1. Home
  2. BWAY vs BNTC Comparison

BWAY vs BNTC Comparison

Compare BWAY & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

N/A

Current Price

$12.60

Market Cap

450.8M

Sector

Health Care

ML Signal

N/A

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

N/A

Current Price

$12.54

Market Cap

371.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BWAY
BNTC
Founded
2003
1995
Country
Israel
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
450.8M
371.0M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BWAY
BNTC
Price
$12.60
$12.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$13.25
$27.67
AVG Volume (30 Days)
89.0K
167.2K
Earning Date
01-01-0001
05-22-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
80.94
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$314.08
N/A
Revenue Next Year
$23.37
N/A
P/E Ratio
$81.98
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.84
$9.85
52 Week High
$26.63
$17.15

Technical Indicators

Market Signals
Indicator
BWAY
BNTC
Relative Strength Index (RSI) 24.03 62.09
Support Level $11.44 $11.30
Resistance Level $17.20 $12.75
Average True Range (ATR) 1.22 0.80
MACD -1.48 0.17
Stochastic Oscillator 5.68 74.58

Price Performance

Historical Comparison
BWAY
BNTC

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Share on Social Networks: